Rhode Island SB 2318: AN ACT RELATING TO FOOD AND DRUGS - DRUG COST TRANSPARENCY ACT (Requires pharmaceutical drug manufacturers and pharmacy benefit managers to provide wholesale acquisition cost/drug prices/rebates/fees/drug sales information to DOH/Insurance Commissioner yearly.)

Status: 03/05/2020 Committee recommended measure be held for further study (as of 2020-03-05)

State: Rhode Island · Session: 2020 · Bill: SB 2318

Subjects: Drugs, Fees, Food and Drugs

Sponsors: Coyne, Goodwin, McCaffrey, Miller, Ruggerio

View Rhode Island SB 2318 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.